Profile：
Academic Research
• Participated in 2 National 12th Five-Year Plan Major Special Projects.
• Completed 6 research projects, including major scientific initiatives of Zhejiang Provincial Department and Ningbo Science and Technology Bureau, as well as general projects from Shenzhen Science and Technology Innovation Commission.
• Recipient of the following awards:
Hainan Provincial Natural Science Award (Second Class)
Jiangsu Provincial Medical Science and Technology Progress Award (Third Class)
Science and Technology Progress Special Award of Health Commission of Zhejiang Province
Sole First Prize awarded by Professor Zhuang Hui of the Chinese Foundation for Hepatitis Prevention and Control (Tianqing Liver Disease Fund)
• Published research on clinical cure of hepatitis B in the top European EASL journal.
• Research cited and promoted in the Chinese Guidelines for the Prevention and Treatment of Hepatitis B and Korean Liver Disease Treatment Guidelines.
• Published 9 SCI papers as first or corresponding author (including co-author) in internationally renowned journals.
• Published over 40 articles in Chinese core journals.
Positions:
Founding National Member, Infection and Control Section, Integrated Physician Branch, Chinese Medical Doctor Association
Special Expert and National Member, National Collaboration Group for Difficult and Critical Liver Diseases
Member, Infectious Disease Committee, Chinese Research Hospital Association
Council Member, China Information Association of Traditional Chinese Medicine
Speciality:
With nearly 30 years of clinical experience, Dr. Li has extensive expertise in the diagnosis and treatment of liver diseases and infectious conditions. He has long been dedicated to research on clinical functional cure of chronic hepatitis B, particularly in the areas of sequential combined interferon therapy with nucleos(t)ide analogues and personalized treatment strategies. He specializes in the comprehensive diagnosis and management of unexplained liver injury and is proficient in interventional techniques such as ultrasound-guided percutaneous liver biopsy. He has conducted years of integrated basic and clinical research on early warning, diagnosis, and intervention of occult liver diseases, as well as blocking and reversing the progression of liver cirrhosis, achieving multiple research outcomes.
